A view of the European Medicines Agency (EMA) headquarters. [AP 연합뉴스 자료사진]
(Brussels = Yonhap News) Correspondent Kim Jong-un = An official from the European Medicines Agency (EMA) assessed that the strategy of repeating a booster shot (boost shot) of the new coronavirus infection (COVID-19) vaccine at short intervals was unsustainable, Reuters, Bloomberg News It was reported on the 12th (local time).
EMA’s head of vaccine strategy, Marco Cavaleri, said at a briefing yesterday: “While the use of additional booster shots may be part of an emergency plan, repeated vaccinations within short intervals will not constitute a sustainable long-term strategy.”
He said a booster shot can be hit once or twice, but it’s not something you can think of as having to be repeated constantly.
He also feared that the strategy of vaccinating the booster shot every four months could put too much strain on people’s immune systems and risk exhausting citizens.
Although the EMA today said the Omicron mutation appears to be more contagious than other mutations, studies from South Africa, the UK, and some EU member states suggest that the risk of hospitalization after infection with the Omicron mutation is lower than with the conventional mutation. said to show
Based on these findings, the EMA added, the risk of hospitalization due to the omicron mutation is estimated to be between one-third and one-half that of the delta mutation.
EMA said recently published study results show that vaccination continues to provide a high level of protection against hospitalization and severe disease associated with omicron mutations, and that boostershots provide better protection than those who receive only the primary dose. added that it suggests
Cavaleri said that additional data on the effect of omicron mutations on vaccines are needed to determine whether a vaccine tailored to the omicron mutation is needed.
kje@yna.co.kr
<저작권자(c) 연합뉴스,
Unauthorized reproduction-redistribution prohibited>
2022/01/12 20:42 Send
